Study number 8530-848
Dates
May 28 2024-Nov 21 2024
Location
Madison, Wisconsin
Age
18-65
Gender
Male or Female
Compensation
$17,665
Group
A1
The investigational drug in this research study is being developed for the treatment of obesity.
The purposes of this study are to look at:
• How well the study drugs are tolerated and any side effects of the study drugs
• The effect of the study drugs on body weight
• How much of the study drug gets into the blood stream and how long it takes the body to get rid of it when given with tirzepatide. Tirzepatide is an investigational drug that has been approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management. The use of tirzepatide in this study is investigational.
Fortrea Madison, WI is recruiting for:
- Healthy Overweight Men and Women, age 18-65
- Body Mass Index between 27-45
- Study involves multiple overnight stays & outpatient visits
- Compensation up to $17,665 may be provided for time and participation
- Refer a friend to receive $300 per qualified referral
Call Now To Schedule Your Screening Appointment!
Group A1:
Check-In: May 28
Check-Out: Jun 2
Check-In: Jun 5
Check-Out: Jun 6
Check-In: Jun 12
Check-Out: Jun 13
Check-In: Jun 19
Check-Out: Jun 20
Check-In: Jun 26
Check-Out: Jun 27
Check-In: Jul 3
Check-Out: Jul 4
Check-In: Jul 10
Check-Out: Jul 11
Check-In: Jul 17
Check-Out: Jul 18
Check-In: Jul 24
Check-Out: Jul 25
Check-In: Jul 31
Check-Out: Aug 1
Check-In: Aug 7
Check-Out: Aug 8
Check-In: Aug 14
Check-Out: Aug 15
Check-In: Aug 21
Check-Out: Aug 22
Check-In: Aug 28
Check-Out: Aug 29
Check-In: Sep 4
Check-Out: Sep 5
Check-In: Sep 11
Check-Out: Sep 15
Follow up Visits: Sep 26, Oct 10, Oct 24, Nov 7, Nov 21